← back to search

Di Wang

Harbin Medical University · CN
Area of research
Genetics · Molecular Biology
Research interest
Research focused on Glioma and Cancer research, with related work in Immune system, Temozolomide, Carcinogenesis. Notable publications include 'Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations', 'Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial', and 'A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma'.
h-index
citations
420
works
7
NIH funding
primary concept
email

Recent publications

Comprehensive characterization of respiratory genes based on a computational framework in pan-cancer to develop stratified treatment strategies
PLoS Computational Biology 2025cited by 1position: middledoi
EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
Genes 2023cited by 14position: middledoi
Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial
EClinicalMedicine 2022cited by 96position: middledoi
A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
CNS Neuroscience & Therapeutics 2022cited by 35position: middledoi
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
Frontiers in Immunology 2021cited by 10position: middledoi
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations
Oncogene 2020cited by 264position: middledoi
Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
Bioscience Reports 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2020–2023)Wei Zhang · South China Agricultural University3 papers (2020–2023) · 3 papers (2020–2023)Zhongfang Shi · Harbin Medical University2 papers (2020–2023)Wenhua Fan · Shihezi University2 papers (2021–2022)Mingchen Yu · Ningbo University2 papers (2021–2023)Tao Jiang · Xinjiang Medical University2 papers (2021–2022) · 2 papers (2020–2021) · 2 papers (2021–2023)Junwei Wang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2025–2025)Liming Chen · Sun Yat-sen University Cancer Center1 papers (2022–2022)Ping Lü · First Affiliated Hospital of Xinxiang Medical University1 papers (2020–2020)Chi Liu · Guangzhou University of Chinese Medicine1 papers (2023–2023)Chenyu Liu · Harbin Medical University1 papers (2025–2025)Wei Yan · Nanjing University of Chinese Medicine1 papers (2021–2021)Fan Zeng · China Pharmaceutical University1 papers (2021–2021)Nan Yang · Fudan University1 papers (2020–2020)Jian Li · The First Affiliated Hospital, Sun Yat-sen University1 papers (2025–2025)Di He · Kettering University1 papers (2020–2020)Huirong Liu · Shanghai University1 papers (2022–2022)